RS53162B - Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a - Google Patents

Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a

Info

Publication number
RS53162B
RS53162B RS20140058A RSP20140058A RS53162B RS 53162 B RS53162 B RS 53162B RS 20140058 A RS20140058 A RS 20140058A RS P20140058 A RSP20140058 A RS P20140058A RS 53162 B RS53162 B RS 53162B
Authority
RS
Serbia
Prior art keywords
peg
polyethylene glycol
relapse
herpes
application
Prior art date
Application number
RS20140058A
Other languages
English (en)
Serbian (sr)
Inventor
Peter Vitins
Marcel Langenauer
Paul Martin Scherer
Original Assignee
Devirex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex Ag filed Critical Devirex Ag
Publication of RS53162B publication Critical patent/RS53162B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RS20140058A 2010-07-08 2011-07-08 Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a RS53162B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (1)

Publication Number Publication Date
RS53162B true RS53162B (sr) 2014-06-30

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20140058A RS53162B (sr) 2010-07-08 2011-07-08 Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a

Country Status (20)

Country Link
US (2) US9814743B2 (OSRAM)
EP (1) EP2563374B1 (OSRAM)
JP (1) JP5858994B2 (OSRAM)
KR (1) KR101881175B1 (OSRAM)
CN (1) CN103079574B (OSRAM)
AU (1) AU2011275458B2 (OSRAM)
CA (1) CA2803228C (OSRAM)
DK (1) DK2563374T3 (OSRAM)
ES (1) ES2442928T3 (OSRAM)
HR (1) HRP20140135T1 (OSRAM)
IL (1) IL223582A (OSRAM)
MX (1) MX2012014783A (OSRAM)
PL (1) PL2563374T3 (OSRAM)
PT (1) PT2563374E (OSRAM)
RS (1) RS53162B (OSRAM)
RU (1) RU2643763C2 (OSRAM)
SG (1) SG186937A1 (OSRAM)
SI (1) SI2563374T1 (OSRAM)
WO (1) WO2012004669A1 (OSRAM)
ZA (1) ZA201300177B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53162B (sr) 2010-07-08 2014-06-30 Devirex Ag Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2014130432A1 (en) 2013-02-19 2014-08-28 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
ES2538335T3 (es) * 2013-05-14 2015-06-19 Najöpharm Gmbh I.G. Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes
UY37497A (es) * 2016-11-28 2018-06-29 Aicuris Anti Infective Cures Gmbh Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida
EP3962924A1 (en) 2019-05-03 2022-03-09 Genentech, Inc. Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
WO2021233571A1 (de) * 2020-04-30 2021-11-25 Ninoderm Ug (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) * 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
EP2121027A2 (en) 2007-01-17 2009-11-25 Devirex AG Cyclodextrin formulations
RS53162B (sr) 2010-07-08 2014-06-30 Devirex Ag Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Also Published As

Publication number Publication date
CA2803228A1 (en) 2012-01-12
ZA201300177B (en) 2014-03-26
HRP20140135T1 (hr) 2014-03-28
US20130090389A1 (en) 2013-04-11
JP5858994B2 (ja) 2016-02-10
AU2011275458B2 (en) 2014-11-27
MX2012014783A (es) 2013-04-03
AU2011275458A1 (en) 2013-02-28
RU2013100383A (ru) 2014-08-20
WO2012004669A1 (en) 2012-01-12
RU2643763C2 (ru) 2018-02-05
EP2563374A1 (en) 2013-03-06
HK1180969A1 (en) 2013-11-01
IL223582A (en) 2017-12-31
DK2563374T3 (da) 2014-01-20
EP2563374B1 (en) 2013-11-13
PT2563374E (pt) 2014-01-23
CN103079574B (zh) 2017-04-12
PL2563374T3 (pl) 2014-04-30
JP2013530208A (ja) 2013-07-25
CN103079574A (zh) 2013-05-01
SI2563374T1 (sl) 2014-01-31
CA2803228C (en) 2019-03-12
KR101881175B1 (ko) 2018-07-23
US9814743B2 (en) 2017-11-14
ES2442928T3 (es) 2014-02-14
SG186937A1 (en) 2013-02-28
US20180055875A1 (en) 2018-03-01
KR20130142992A (ko) 2013-12-30

Similar Documents

Publication Publication Date Title
US20180055875A1 (en) Polyethylene Glycol Compositions for Controlling Relapse of Herpes Labialis, Herpes Genitalis, and Herpes Zoster
US10894069B2 (en) Topical antiviral formulations and methods of using the same
US20100111883A1 (en) Cyclodextrin formulations
Stoopler et al. Topical and systemic therapies for oral and perioral herpes simplex virus infections
US9144576B2 (en) Topical antiviral formulations
CN104853759A (zh) 以gpcr19作用剂作为有效成分的过敏性皮肤疾病的预防或治疗用组成物
US20110207696A1 (en) Compositions for treating rosacea
WO2013102885A1 (en) Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
HK1180969B (en) Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
EP2782585B1 (en) Antiviral formulations
EP0078533B1 (en) Medicinal composition for treating skin disorders
BR102016004295A2 (pt) Composição farmacêutica de medicamento à base de própolis
Agent Docosanol Cream, 10%
ITUB20159325A1 (it) Uso di un estratto o concentrato di gelso nero per la preparazione di prodotti cosmetici o integratori alimentari, e prodotti cosmetici o integratori alimentari cosi preparati